
Podcast Strategy
Conversations about your biology, your data, and what you own.
In the next 25 years, more is going to change about your body, your biology, your health, your data, and what you own than has changed in the last century. The show is about who is writing the rules, who is fighting for them, and who they are protecting.
A 25-year health philanthropist simultaneously running a clinical-trial economic-flip company (Consuli, contracting with named pharma sponsors), a chartered AI-and-health-data rules consortium (ATIA), and a consumer biobank product (MyBioBank), all backed by named foundations with bipartisan policy traction in Congress. Operator credibility, philanthropic capital fluency, AI-infrastructure governance, bipartisan policy traction, and consumer-facing institutional product all in one person. The combination does not exist anywhere else in this conversation.
This strategy is designed to show you how our process works — how we think about media and how we get you in front of the people who matter most to your organization. These five core principles are the lens through which we build every strategy, so you can see exactly how we’ll make you successful.
Each lane has a real pain in their own voice, a reachable subset in year one, and a pre-warmed pool the show can convert.
Five proven levers, distilled from 180M+ downloads and 200+ founders. Together they are the system that allows a business to win. Click any card to expand the principle in detail.
Industry Thought Leader is the practice of producing media that positions you and your organization as the leading voice in your category. There is an art to this. It works by speaking directly to every flavor of motivation an audience brings, so the people you most want to reach actually see themselves in the work and convert into your universe.
The way we do it is simple: tailor every piece of content to a specific audience problem. We interweave case studies, human stories, and concrete value across all four lanes so each motivation type has something to grab onto. We call this hacking the back of the brainstem— speaking to the real challenge sitting in the audience’s head before anything else.
Below: the four lane-specific challenges this show is built to answer, plus the cross-lane challenge underneath them all, each paired with the content solution we’d build for it.
A senior staffer is being asked to mark up a genetic privacy bill, an AI-in-healthcare provision, or a child-data-protection clause without a clean mental model of what induced pluripotent stem cells, autologous CAR-T, AI-mediated diagnostics, and biobank custody actually do. Elizabeth opens with a structured ground-truth briefing on the science and governance gaps a bill needs to anticipate.
A specialty AI founder building an oncology, cardiometabolic, or behavioral-health AI has the modeling talent, the team, and a paying pilot. What they do not have is consented patient data at the scale and provenance their next legal review will demand. Elizabeth walks through what failed in the consumer-data-cooperative wave (LunaDNA, Nebula Genomics, Embleema, Hu-manity), what Datavant and Komodo Health solve for pharma, and what ATIA is built to provide for AI builders specifically.
A program officer or CIO at a $200M to $2B health-focused foundation has watched RWJF commit $625M and Skoll Foundation deploy 80% of endowment in social impact. They want to do something similar but cannot find a credible health-data-infrastructure vehicle that survives the toughest skeptic on their board. Elizabeth hosts that skeptic out loud: a peer foundation principal walking through how they sized the thesis.
1.9 million people requested that 23andMe delete their genetic data after the bankruptcy filing. Many discovered that requesting deletion and verifying deletion are not the same thing. The show talks directly to the consumer who lived this and is now ready to think about biological data sovereignty as an asset, not just a worry.
A foundation, an academic center, a patient advocacy organization, or an AI builder is doing important work, sending it to congressional staffers, and watching it land in a few inboxes. Elizabeth makes the structural argument for why category-defining work needs a centerpiece conversation, not just a library.
The Mini Celebrity Effect is the idea that you only need to be known by your ideal audience. We focus on the 1,000 true fans principle — one thousand of the right people seeing you as the go-to person in your field.
The way to do this is to create perception. When the audience sees the content, the show, and the brand, they should be looking at someone with high status, authority, deep knowledge, lived experience, and a serious network around them. The people we want to reach need to walk away with the right impression of the problems we are solving and the company we are solving them with.
The effect is built by combining two things: your subject-matter expertise and the quality of your network. Together they position the founder and the organization as the trusted, sought-after figure inside the niche. Below: the four lane-specific strategies that put those two elements to work.
The Lead Flow Tap is the system that turns the show into a continuous, predictable inflow of the right people. Every episode is a public-facing artifact, but underneath it sits a LinkedIn outreach engine reaching 1,000 targeted prospects per month across the four lanes the trust actually needs to convert.
The way we think about this is simple: every individual the show is built to reach is a target. Not an abstract audience segment — a specific person, in a specific seat, with a specific reason to lean in. The four targets below are the four kinds of people the show converts: the staffer writing the bill, the founder hitting the data wall, the foundation principal sizing the thesis, the consumer who already lost their data once.
For each target we name why they convert and what the show compounds into — the strategic value the trust actually gets when this person enters the universe. Underneath that, we map the market opportunity — where this audience lives, how big it is, and the funnel that turns reach into qualified conversations every month.
Your Biology and Future is built around four named audiences. We size the total audience the show can plausibly reach, narrow it to the serviceable obtainable market we actually convert, show where that audience already lives, and then walk the monthly funnel that turns reach into compounding conversations.
LinkedIn is where the four lanes converge. It is also where the platform itself is moving the audience the show needs.
Senior congressional staffers, health-AI founders, and foundation program officers all maintain active LinkedIn presences. It is the primary content and social-connection platform for the B2B layer of the show, and it is where authority transfer is most visible: titles, employer history, and endorsements are public, so credibility moves with the post.
The platform is also accelerating in exactly the formats the show is built to win on. Video viewership on LinkedIn grew +36% year-over-year in early 2025, and video creation is growing at twice the rate of other post formats (Digiday, 2025). Cross-platform benchmarks show video impressions up 73% and video views up 52% from 2024 to 2025 (Teleprompter / Metricool 2026), while post comments rose 24% YoY in the most recent quarter (Social Media Today, Oct 2025). The 2025 Edelman + LinkedIn B2B Thought Leadership Report makes the strategic case explicit: thought leadership content opens doors with senior buyers that ads and traditional sales cannot (Edelman + LinkedIn, 2025).
Translation for the show: founders and operators who put long-form video and consistent content on LinkedIn right now are getting disproportionately in front of the exact decision-makers the trust needs — staffers, AI founders, foundation principals — and the platform’s own algorithm is amplifying that work.
A custom LinkedIn outreach system that compounds attention into qualified conversations every month.
The Mirror Effectis how you become omnipresent in the mind of your ideal buyer or audience member. What we’re after is strategic omnipresence — a deliberate act of staying top of mind across platforms, formats, and channels.
The way to think about it is as a touchpoint journey: every individual moves from awareness to conversion through repeated, consistent contact with your work. The biggest brands and creator-founders all understand this, and so does every paid-ad strategy ever built. The math is simple — the more often the right person sees the right content, the more likely they convert.
To create that journey, we build the Mirror Flywheel: record long-form episodes, slice them into dozens of high-impact assets, distribute them across every relevant platform, and recirculate the wins. One long-form piece becomes dozens of touchpoints. The effect builds mental stickiness, increases conversion rates, and compresses the time from discovery to decision.
Each long-form episode feeds 8-20+ touchpoints across LinkedIn, YouTube, Instagram, email, and the blog. The flywheel runs continuously, not in campaigns.
One of Oneis how you become the only choice in everyone’s mind. This is the final principle — what everything else in the strategy layers up to. This is category ownership: when your brand, your voice, and your frameworks show up consistently, people stop comparing you to anyone else and start associating you as the only person who actually solves their problem.
Our system builds that message into your podcast, your content, your LinkedIn, your videos, your features, and the rest of your ecosystem. The objective is that when anyone in your audience thinks or searches the questions below, they don’t deliberate, they don’t go hunting for alternatives. They think of you, and they call you.
Grouped by what each one is. Direct attempts that did not work, indirect B2B players, and aspirational benchmarks the show treats as guests.
Peers graded by audience and format proximity. The operator-philanthropist seat — the one Your Biology and Future is built for — is empty across this entire set.
| Show | Host · Network | Cadence | Lane | Peer fit | Gap vs Your Biology and Future |
|---|---|---|---|---|---|
| TradeoffsAppleSitePenn LDI | Dan GorensteinIndependent (RWJF / CHCF / Penn LDI funded) | Biweekly | Health policy journalism | Closest peer | Closest production and funding peer in the set. NYT Daily-style narrative format directly maps to where this show could go; foundation-funding model maps to how it could be sponsored. Lane gap is journalism vs operator — Gorenstein analyzes; Elizabeth builds. Rarely covers biodata sovereignty, biology + AI infrastructure, or consumer biobanking. |
| Ground TruthsAppleSpotifySubstackYouTube | Eric Topol, MDSubstack / Scripps Research | Weekly | AI in medicine (academic-clinical) | Adjacent | Strongest known voice on AI in medicine. High-credibility academic-clinical lens; Topol speaks doctor-to-doctor. Real audience overlap with this show’s clinician and AI-builder lanes, but Topol is positioned as a clinician analyzing the field, while Elizabeth is positioned as an operator building inside it. No policy lens, no consumer surface, no operator-as-builder seat. |
| Medicine and the MachineAppleSpotifyMedscape | Eric Topol + Abraham VergheseMedscape | Weekly | Clinician-humanism on AI in medicine | Adjacent (lighter) | Same lane as Ground Truths but more clinician-humanism balance via Verghese’s storytelling sensibility. Even more clinician-centric than Ground Truths and locked to Medscape’s editorial frame. Same gaps as Ground Truths: no policy, no consumer, no operator. |
| Raising Health (formerly Bio Eats World)a16zApple | Olivia Webb / Kris TatiossianAndreessen Horowitz (a16z) Bio + Health | ~Weekly | VC + biotech operator | Adjacent | VC frame everywhere. Strong founder access; speaks operator-to-operator on the AI-and-biology side. Real audience overlap with the specialty health-AI builder lane, but Elizabeth occupies a different seat (operator-philanthropist vs VC-operator) with different capital fluency (philanthropic + endowment vs venture). No policy lens, no consumer biology surface, no philanthropic / impact-investing frame. |
| The Long RunAppleSpotifySite | Luke TimmermanTimmerman Report | Semimonthly | Biotech / pharma insider | More removed | Pharma-insider lane with CEO-grade guest pipeline (Moderna, BridgeBio, Xaira, Penn CAR-T, Blueprint). Insider-to-insider conversations. Audience touches policymakers and AI builders but lives a step removed from the seats this show targets. Useful as a guest-relationship reference, not a competitive peer. |
| POLITICO Pulse CheckApple | Chelsea CirruzzoPOLITICO | Weekly | Health policy news (reporter-driven) | Adjacent (lighter) | Tight news cycle, real staffer reach via POLITICO’s distribution. Reporter-driven journalism rather than operator-led depth. News-driven and ephemeral; no through-line, no narrative arc, no operator perspective, low biology depth. Useful as a topical-cycle reference, not a competitive peer for the operator-philanthropist seat. |
| Your Biology and Future | Elizabeth DreicerThe Global BioData Trust | Weekly | Operator-philanthropist | The empty seat | Long-form video interviews. Operator credibility, philanthropic capital fluency, AI-infrastructure governance, bipartisan policy traction, and consumer-facing institutional product — in one seat. No one currently sits here. |
10 years. 180M+ downloads. 200+ founders behind these covers.

Founder, Bulletproof / Upgrade Labs
Market-maker platform aggregating top voices in health and wellness.

CEO & Founder, MBCA Consulting
From near-zero online presence to front and center in medtech.
“In May of this year, my presence online was pretty much nonexistent. And since that time, really, this podcast has taken front and center.”Listen to the show →

Practitioner & author, women's health and hormones
6M+ downloads. Definitive voice for women in health and hormones.

Founder, Full Spectrum Financial Solutions
Dozens of new qualified prospects every month. A direct referral engine.

Medtech industry expert / consultant
Multi-7-figure US Government contract in negotiation within 3 months.

Investor & founder, Professional Capital Management
A top-performing finance / crypto podcast and growth engine for his firm.

Founder & host, Politicology
Top-10 debut. Tens of millions of downloads. Webby Award nomination.

Founders, Optimize Group
Sales call closing rate jumped from 40% to 70% after guests appeared.

Founders, Starfish
Hundreds of new non-profits onboarded to the Starfish platform monthly.

President, LearningZen
90%+ targeting accuracy. So many booked calls he considered pausing campaigns.
“I was overwhelmed by how many connections we were making. I either need to hire somebody, pause the campaign. I've got so many people interested in speaking with me.”

COO, CultureWorks
20+ qualified matches a month. The right guests now come to her.
“The aha was, holy manoli, they're reaching out to me. I'm getting people book in time with me who I want to talk to and that's magical.”Listen to the show →

Political action committee
$60M+ in Super PAC fundraising driven by the media system.
The phase structure is in place. Specifics — lane focus, primary strategy per phase, and recruitment outcome — are to be discussed and locked on our next step call.